- Home
- EXEL vs REXR Comparison
EXEL vs REXR Comparison
Compare EXEL & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- REXR
- Stock Information
- Founded
- EXEL 1994
- REXR 2013
- Country
- EXEL United States
- REXR United States
- Employees
- EXEL N/A
- REXR N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- REXR Real Estate Investment Trusts
- Sector
- EXEL Health Care
- REXR Real Estate
- Exchange
- EXEL Nasdaq
- REXR Nasdaq
- Market Cap
- EXEL 10.4B
- REXR 8.6B
- IPO Year
- EXEL 2000
- REXR 2013
- Fundamental
- Price
- EXEL $37.88
- REXR $42.91
- Analyst Decision
- EXEL Buy
- REXR Hold
- Analyst Count
- EXEL 21
- REXR 9
- Target Price
- EXEL $43.65
- REXR $40.67
- AVG Volume (30 Days)
- EXEL 2.4M
- REXR 2.6M
- Earning Date
- EXEL 10-28-2025
- REXR 10-15-2025
- Dividend Yield
- EXEL N/A
- REXR 4.01%
- EPS Growth
- EXEL 81.76
- REXR 11.21
- EPS
- EXEL 2.08
- REXR 1.35
- Revenue
- EXEL $2,230,005,000.00
- REXR $986,532,000.00
- Revenue This Year
- EXEL $9.24
- REXR $9.35
- Revenue Next Year
- EXEL $13.04
- REXR $6.25
- P/E Ratio
- EXEL $18.24
- REXR $31.86
- Revenue Growth
- EXEL 10.73
- REXR 13.72
- 52 Week Low
- EXEL $25.12
- REXR $29.68
- 52 Week High
- EXEL $49.62
- REXR $52.37
- Technical
- Relative Strength Index (RSI)
- EXEL 44.99
- REXR 70.54
- Support Level
- EXEL $36.23
- REXR $40.06
- Resistance Level
- EXEL $38.95
- REXR $42.65
- Average True Range (ATR)
- EXEL 0.85
- REXR 0.91
- MACD
- EXEL 0.13
- REXR 0.25
- Stochastic Oscillator
- EXEL 60.66
- REXR 97.80
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.